• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端组蛋白乙酰转移酶 NAA40 通过控制 AGR2 的表达来调节骨肉瘤进展。

N-terminal histone acetyltransferase NAA40 modulates osteosarcoma progression by controlling AGR2 expression.

作者信息

Wu Hanhua, Xu Hua, Man Yunan, Huang Piwei, Huang Linhai, He Maolin

机构信息

Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuangyong Road 6, Nanning, Guangxi Zhuang Autonomous Region, 530021, PR China.

Center for Education Evaluation & Faculty Development, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, PR China.

出版信息

Biochem Biophys Res Commun. 2025 Mar 25;754:151491. doi: 10.1016/j.bbrc.2025.151491. Epub 2025 Feb 14.

DOI:10.1016/j.bbrc.2025.151491
PMID:40020320
Abstract

PURPOSE

Osteosarcoma (OS) is the most common primary malignant bone neoplasm in children and adolescents, characterized by high mortality and disability owing to frequent relapse and metastasis. However, N-alpha-acetyltransferase 40 (NAA40) molecular mechanisms underlying OS progression and metastasis remain unexplored.

METHODS

Bioinformatics analysis was used to evaluate NAA40 role in OS data from GEO and TARGET database. OS cell multiplication, invasion and migration were gauged in CCK8, EdU assays, and Transwell assays. RT-qPCR, ChIP-qPCR, dual luciferase reporter assay and rescue experiments were to explore NAA40 regulatory mechanism. Animal experiments further confirmed cell-based assays and NAA40 molecular mechanism.

RESULTS

Herein NAA40 expression was upregulated in OS samples and associated with shorter survival among patients. Functionally, NAA40 depletion resulted in reduced OS cell viability, decreased migration, and invasion in vitro. Mechanistically, NAA40 loss was associated with increased H4S1ph and H4R3me2a and decreased H4R3me2s.NAA40 overexpression improved the transcriptional activity in the promoter of AGR2. Histone marks, H3K4me3 and H3K27me3, at the AGR2 promoter were altered, inducing changes in AGR2 expression in NAA40-depleted OS cells. Anterior gradient 2 (AGR2) was identified as a downstream target of NAA40.AGR2 knockdown in OS cells resulted in reduced viability, decreased migration, and invasion. Ectopic overexpression of AGR2 partially rescued these phenotypic changes. In vivo experiments revealed that NAA40 depletion led to reduced AGR2 protein levels, inhibiting the proliferative and metastatic potential of OS cells.

CONCLUSION

NAA40 contributes to OS development and progression by epigenetically regulating AGR2 expression.

摘要

目的

骨肉瘤(OS)是儿童和青少年中最常见的原发性恶性骨肿瘤,因其频繁复发和转移导致高死亡率和致残率。然而,N-α-乙酰转移酶40(NAA40)在骨肉瘤进展和转移中的分子机制仍未被探索。

方法

利用生物信息学分析评估NAA40在来自GEO和TARGET数据库的骨肉瘤数据中的作用。通过CCK8、EdU实验和Transwell实验检测骨肉瘤细胞的增殖、侵袭和迁移。采用RT-qPCR、ChIP-qPCR、双荧光素酶报告基因实验和拯救实验来探索NAA40的调控机制。动物实验进一步证实了基于细胞的实验结果和NAA40的分子机制。

结果

在此研究中,NAA40在骨肉瘤样本中表达上调,且与患者较短的生存期相关。在功能上,NAA40缺失导致骨肉瘤细胞活力降低,体外迁移和侵袭能力下降。在机制上,NAA40缺失与H4S1ph和H4R3me2a增加以及H4R3me2s减少有关。NAA40过表达提高了AGR2启动子的转录活性。AGR2启动子处的组蛋白标记H3K4me3和H3K27me3发生改变,导致NAA40缺失的骨肉瘤细胞中AGR2表达发生变化。前梯度蛋白2(AGR2)被确定为NAA40的下游靶点。在骨肉瘤细胞中敲低AGR2导致细胞活力降低、迁移和侵袭能力下降。AGR2的异位过表达部分挽救了这些表型变化。体内实验表明,NAA40缺失导致AGR2蛋白水平降低,抑制了骨肉瘤细胞的增殖和转移潜能。

结论

NAA40通过表观遗传调控AGR2的表达促进骨肉瘤的发生和发展。

相似文献

1
N-terminal histone acetyltransferase NAA40 modulates osteosarcoma progression by controlling AGR2 expression.N 端组蛋白乙酰转移酶 NAA40 通过控制 AGR2 的表达来调节骨肉瘤进展。
Biochem Biophys Res Commun. 2025 Mar 25;754:151491. doi: 10.1016/j.bbrc.2025.151491. Epub 2025 Feb 14.
2
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.miR-624-5p 通过靶向 PTPRB 抑制 hippo 信号通路促进骨肉瘤细胞的发生和转移。
J Exp Clin Cancer Res. 2019 Dec 11;38(1):488. doi: 10.1186/s13046-019-1491-6.
3
AGR2 facilitates teratoma progression by regulating glycolysis via the AnXA2/EGFR axis.AGR2 通过 AnxA2/EGFR 轴调节糖酵解促进畸胎瘤进展。
Exp Cell Res. 2024 Sep 1;442(1):114228. doi: 10.1016/j.yexcr.2024.114228. Epub 2024 Aug 26.
4
Anterior gradient 2 regulates cancer progression in ‑wild‑type esophageal squamous cell carcinoma.前梯度 2 调控野生型食管鳞状细胞癌的癌症进展。
Oncol Rep. 2021 Dec;46(6). doi: 10.3892/or.2021.8211. Epub 2021 Oct 29.
5
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.MALAT1基因敲低通过调控miR-34a/细胞周期蛋白D1轴抑制骨肉瘤进展。
Int J Oncol. 2019 Jan;54(1):17-28. doi: 10.3892/ijo.2018.4600. Epub 2018 Oct 19.
6
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.LINC02273 通过表观遗传增加 AGR2 转录来驱动乳腺癌转移。
Mol Cancer. 2019 Dec 19;18(1):187. doi: 10.1186/s12943-019-1115-y.
7
MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.miR-501-3p 通过靶向 BCL7A 促进骨肉瘤细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):624-633. doi: 10.1007/s13577-020-00468-x. Epub 2021 Jan 7.
8
Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis.HCG18 通过靶向 miR-188-5p/FOXC1 轴抑制小儿骨肉瘤细胞活力、迁移和侵袭。
Mol Biotechnol. 2021 Sep;63(9):807-817. doi: 10.1007/s12033-021-00343-6. Epub 2021 May 26.
9
KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.KDM6B介导的乳酸脱氢酶A的组蛋白去甲基化促进骨肉瘤肺转移。
Theranostics. 2021 Feb 6;11(8):3868-3881. doi: 10.7150/thno.53347. eCollection 2021.
10
Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.通过抑制基质金属蛋白酶-9,敲低S100A4可降低骨肉瘤细胞的肿瘤发生和转移。
Asian Pac J Cancer Prev. 2011;12(8):2075-80.

引用本文的文献

1
Agr2 in cancer and beyond: unraveling its role during protein synthesis, ER stress, and as a predictive biomarker.Agr2在癌症及其他领域:揭示其在蛋白质合成、内质网应激过程中的作用以及作为预测性生物标志物的作用
Mol Cell Biochem. 2025 Jun 5. doi: 10.1007/s11010-025-05318-8.